Menü mobile menu

Mitarbeiter

Dr. Hannah Kleine-Weber

ehemalige Promovierte Wissenschaftlerin

Infektionsbiologie

+49 551 3851-151

HKleine-Weber(at)dpz.eu

Kellnerweg 4
37077 Göttingen

Kleine-Weber, H., Elzayat, M.T., Hoffmann, M., Pöhlmann, S.,Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Sci Rep. 2018 Nov 9;8(1):16597. PMID: 30413791. IF: 3.9

Kleine-Weber H, Elzayat MT, Wang L, Graham BS, Müller MA, Drosten C, Pöhlmann S, Hoffmann M., 2019. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization J Virol. 2019 Jan 4;93(2). pii: e01381-18. PMID: 30404801. IF: 4.3

Kleine-Weber H., Hoffmann, M., Pöhlmann, S.,Spike proteins of novel MERS-coronavirus isolates from North- and West-African dromedary camels mediate robust viral entry into human target cells. Virology. 2019 Sep;535:261-265. PMID: 31357164. IF: 2.8

Kleine-Weber H, Schroeder S, Krüger N, Prokscha A, Naim HY, Müller MA, Drosten C, Pöhlmann S, Hoffmann M., Polymorphisms in dipeptidyl peptidase 4 reduce host cellentry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2020 Jan 21;9(1):155-168. PMID: 31964246. IF: 5.8

Hoffmann M*, Kleine-Weber H*, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S., 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor., Cell. 2020 Mar 4. pii: S0092-8674(20)30229-4. PMID: 32142651 *, equal contribution mark. IF: 38.6

Hoffmann M, Schroeder S, Kleine-Weber H, Müller MA, Drosten C, Pöhlmann S., 2020, Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19., Antimicrob Agents and Chemother. 2020 Apr 20. pii: AAC.00754-20. PMID: 32312781. IF: 4.7

Hoffmann M, Kleine-Weber H, Pöhlmann S., 2020, A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020 Apr 28. pii: S1097-2765(20)30264-1. PMID: 32362314. IF: 15.5

Hoffmann M, Mösbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Krüger N, Gassen NC, Müller MA, Drosten C, Pöhlmann S., 2020, Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2., Nature. 2020 Jul 22. doi: 10.1038/s41586-020-2575-3. PMID: 32698190. IF: 42.7

Pfaender S, Mar KB, Michailidis E, Kratzel A, Boys IN, V’kovski P, Fan W, Kelly JN, Hirt D, Ebert N, Stalder H, Kleine-Weber H, Hoffmann M, Hoffmann H-H, Saeed M, Dijkman R, Steinmann E, Wight-Carter M, McDougal MB, Hanners WN, Pöhlmann S, Gallagher T, Todt D, Zimmer G, Rice CM, Schoggins JW, Thiel V., 2020, LY6E impairs coronavirus fusion and confers immune control of viral disease., Nat Microbiol.2020 Jul 23. doi: 10.1038/s41564-020-0769-y. PMID: 32704094. IF: 15.5

Zurück zur Übersicht